Eye Health Supplements Market

Eye Health Supplements Market Analysis by Lutein & Zeaxanthin, Omega-3 Fatty Acids, Antioxidants, Coenzyme Q10, Flavonoids, Alpha-lipoic Acid, Astaxanthin, and Others from 2023 to 2033

Analysis of Eye Health Supplements Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Eye Health Supplements Market Outlook (2023 to 2033)

The valuation of the global eye health supplements market stands at US$ 1.9 billion in 2023. Global demand for eye health supplements is forecasted to reach US$ 3.5 billion by the end of 2033, increasing at a CAGR of 6.2% over the forecast period (2023 to 2033).

Various prominent as well as regional manufacturers and government bodies are trying to increase awareness about eye health owing to the increasing aging population and rising prevalence of eye-related disorders globally. To reduce or minimize the cost of treatments, several public bodies are putting efforts to encourage people for the consumption of nutritional supplements and products. They are used as maintenance and preventive medicine for eye health.

Growing prevalence of eye disorders, especially in the elderly population, is predicted to fuel demand for eye health supplements. Various eye problems occur due to aging and therefore appropriate treatment and precautionary medicines for maintaining eye health are required. The utilization of eye health products, including supplements, is an effective way to treat different eye issues, which arise due to aging.

  • Based on indication, age-related macular degeneration accounted for 32% revenue share of the global market in 2022.

The appropriate use of eye health supplements is helpful to treat various disorders, including cataracts, macular degeneration retinopathy, trachoma, optic neuritis, dry eye syndrome, and infections. Moreover, rising cases of vision impairment along with the increasing prevalence of myopia are due to growing screen time along with engagement in virtual meetings while working from home.

High myopia is related to the increased risk of various degenerative eye diseases, including glaucoma and cataracts. The target industry is also driven by the growing preference for different eye health supplements among millennials, who are more susceptible to digital eye fatigue and myopia.

Stringent regulations surrounding product safety, manufacturing, and efficacy claims are expected to hamper market expansion over the forecasted period. There are regional differences in regulations. Some regions do not permit health benefit claims, whereas some do. Therefore, these factors are expected to directly impact product demand.

Fact.MR, a provider of market research and competitive intelligence, provides a holistic analysis of the global eye health supplements market. The newly published research report has a detailed analysis of growth opportunities, key trends, regional overview, competitive landscape, and other aspects.

Report Attributes

Details

Market Size in 2023

US$ 1.9 Billion

Forecasted Market Value (2033)

US$ 3.5 Billion

Global Market Growth Rate (2023 to 2033)

6.2% CAGR

Revenue Share of Lutein & Zeaxanthin (2022)

32%

Revenue Share of Tablets (2022)

41%

Key Companies Profiled

  • The Nature’s Bounty Co.
  • Pfizer Inc.
  • Vitabiotics Ltd.
  • Bausch & Lomb
  • Kemin Industries, Inc.
  • Amway International
  • EyeScience
  • Wellbeing Nutrition
  • Nutrivein
  • ZeaVision LLC
  • Nutrachamps
  • Kemin Industries, Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Determinants are Contributing to Rising Demand for Eye Health Supplements?

“Increasing Cases of Vision Impairment Among Global Population”

There has been a significant increase in the incidence of vision impairment among people around the world, which is expected to boost the demand for eye health supplements.

For instance :

  • According to the data provided by World Health Organization in October 2020, around one billion around the world were suffering from vision impairment.

Vision impairment is caused owing to multiple reasons, including congenital and hereditary abnormalities, toxicosis, injuries to the eyes, and acquired eye diseases, including trachoma, glaucoma, cataract, optic neuropathy, disorders of the cornea, ametropia, disorders of retina and choroid, amblyopia, and others. Therefore, rising cases of eye-related disorders around the world are projected to generate demand for eye health supplements, which can help in the effective functioning of the eyes.

“R&D Activities and Product Approvals - Opening New Avenues for Suppliers of Eye Health Supplements”

Increasing concentration on the development of supplements is expected to bolster growth opportunities in the target market.

For instance :

  • Atlas Nanotech is a company operating in nanotechnology research and development and is a subsidiary of COSTAS, Inc. The company is concentrating on nanomedicine. In January 2019, the company announced the completion of the first-ever nanotechnology vitamin A (retinol)-based crystalline eye drop. This product is planned to be sold under NANO CLEAR A trade name and is indicated for dry eye diseases.

Which Factors are Negatively Impacting Eye Health Supplements Market Expansion?

“Implementation of Stringent Regulations for Production of Eye Health Supplements”

Certain stringent regulations are imposed by governing bodies to produce eye health supplements, which is estimated to limit market growth.

For instance :

  • In June 2020, the Food Safety and Standards Authority of India alerted food safety commissioners of all Indian states to ensure the RDA (recommended dietary allowances) values of health supplements, which include eye health supplements, including amino acids, minerals, and vitamins in food products. These values should not be exceeded in products for the Indian population.

A lack of knowledge or ignorance of these values is anticipated to have adverse impacts on the quality and demand for final products and therefore expansion opportunities are also restricted.

“Dearth of Facilities for Identification of Dry Eye Disease in Developing Economies”

There is no single authentic test available for the diagnosis of dry eye diseases among people from developing economies. Therefore, sometimes it becomes difficult to diagnose diseases, which are predicted to have a direct impact on the demand for eye health supplements.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

How are New Market Entrants Transforming the Eye Health Supplements Landscape?

“Product Launches - Key to Eye Health Supplements Market Expansion”

New players, who are exploring avenues in the global market are investing a significant amount of money in product innovation to provide more effective supplements.

For instance :

  • Nippon Flour Mills is a Japan-based company. In August 2019, the company entered into the healthcare domain with the launch of brain and eye supplements, which are made from lutein and zeaxanthin.

Eye health supplements market size, demand, growth and sales forecast by Fact.MR

Why are Manufacturers of Eye Health Supplements Looking to Invest in North America?

“Rising Cases of Eye Disorders in the Region”

Rising geriatric population, growing cases of diabetes, and different eye disorders, including cataracts, diabetic retinopathy, AMD (age-related macular degeneration), and other eye diseases are predicted to boost growth opportunities in North America. Macular degeneration, which is generally addressed as AMD, is an eye disorder related to aging and further results in damaged central and sharp vision.

  • Macular degeneration, according to Macular Degeneration Research 2021, is considered a prominent reason for vision loss among Americans who are of 60 years and more.

Age is a significant risk factor for macular degeneration. The risk to get advanced AMD can increase from 2% for people aged 50-59 to 30% who are above the age of 75. Moreover, increased investment along with new product launches by key players in North America is predicted to aid market growth.

For instance :

  • In July 2019, Bausch and Lomb launched Ocuvite Eye Performance, which is a vitamin supplement for eye health. It is produced with seven crucial nutrients, which are helpful in strengthening the macula.

Players operating in the region are investing in R&D activities, acquisitions, and collaborations to expand their product portfolio.

For instance :

  • In November 2019, Zea Vision LLC entered into a partnership with the Boston Red Sox as an official brand for eye vitamins.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Country-wise Insights

What Makes the United States a Hub for Eye Health Supplements?

“Increased Cases of Eye Disorders Bolstering Demand for Eye Nutrition Supplements”

  • According to CDC (Centers for Disease Control and Prevention), eye disorders or diseases are very common in the United States. Around 4.2 million Americans, who are of 40 years and above either have low vision or are blind.

Cataracts, age-related macular degeneration, amblyopia, and glaucoma are some major disorders or diseases, which are found in Americans. Red eyes, eye strain, lazy eyes, night blindness, etc., are symptoms of eye health disorders or diseases. Ophthalmologists prescribe eye health supplements, including zinc, lutein and zeaxanthin, vitamin C, omega-3 fatty acids, and vitamin B1, which is predicted to boost their sales in the United States.

Why are Manufacturers of Eye Health Supplements Investing in Germany?

“Increased R&D Activities for Production of Effective Eye Health Supplements”

Germany held 5.2% share of global revenue in 2022. Increased R&D activities, growing requirements for innovative and more effective eye health products, and the rapidly developing insurance sector are projected to generate growth opportunities. The availability of an efficient supply chain management system in Germany is also contributing to revenue share.

Category-wise Insights

Which Ingredients are Widely Used in Eye Health Supplement Production?

“Rising Awareness about Benefits of Lutein & Zeaxanthin Supplements for Eye Disorders”

Lutein and zeaxanthin, omega-3 fatty acids, antioxidants, coenzyme Q10, flavonoids, alpha-lipoic acid, astaxanthin, and others are key ingredients used in the production of eye health supplements. Among these, lutein and zeaxanthin ingredients are used significantly in eye health supplements. The segment held around 32% of the global revenue in 2022.

Growing awareness about the benefits of lutein and zeaxanthin supplements to prevent and provide effective treatment against different eye disorders, especially diabetic retinopathy, cataract, uveitis, and AMD is contributing to their increased demand. In addition, the increasing prevalence of eye disorders and recommendations for eye health supplements by clinicians, vision scientists, and ophthalmologists are driving market growth.

Which Indication is Stimulating High Demand for Eye Health Supplements?

“Age-related Macular Degeneration - Most Common Reason for Blindness”

Based on indication, the global industry is classified into age-related macular degeneration, cataract, dry eye syndrome, inflammation, and others. Age-related macular degeneration held a 32% share of the global revenue in 2022. The increasing global prevalence of age-related macular degeneration is contributing to market growth.

AMD is reported as the third most vital reason for blindness across the globe. It further leads to blindness among higher-income countries with a significant aging population.

  • According to BrightFocus Foundation, approximately 11 million people from the United States encountered some form of AMD in 2019, which is expected to reach around 22 million by the end of 2050. The number of patients experiencing macular degeneration, globally, was 196 million in 2020 and is forecasted to reach 288 million by the end of 2040.

What Makes Tablet-based Eye Health Supplements Popular among Patients?

“Easy and High Availability of Supplements in Tablet Formulation”

Tablets, capsules, powder, softgels, and liquid are the key forms in which eye health supplements are available across the globe. Among these, tablet-based eye health supplements held 41% of the global market revenue in 2022. Increasing preference for tablet-based eye health supplements due to their easy and high availability in different forms, including sublingual and buccal tablets, sustained-release tablets, and chewable tablets is boosting their sales.

Tablets are comparatively cheaper than other formulations. Moreover, patients from different age groups are widely accepting these forms, which is predicted to contribute to their rising demand. The longer shelf-life of tablets compared to liquid and powder forms is also stimulating their sales.

Demand for softgel-based eye health supplements is expected to increase at a noteworthy rate. Softgels are considered an effective form of eye health supplement. Researchers advocate the effectiveness of supplements in native form compared to modified forms.

Key Market Players

Top brands producing eye health supplements are investing in the improvisation of their systems used for supply chain management. Companies are investing a significant amount in new developments to offer more qualitative products to end users with a variety of flavors. Moreover, governing bodies are implementing regulatory frameworks to reduce environmental impacts and to ensure the availability of quality products in the global market.

Prominent players are focusing on the development of more efficient eye health supplements to gain lucrative opportunities in the market.

For instance :

  • In April 2022, Wellbeing Nutrition released ‘Melts Eye Care’, which is the first all-natural eye vitamin in the world. This internationally recognized brand uses advanced nanotechnology for the delivery of vitamins directly into the bloodstream. It makes the bloodstream more bioactive and bioavailable compared to conventional capsules and tablets.
  • In October 2020, Nature’s Way invested in the manufacturing of supplements for kids to ensure better health for them. The company announced the launch of dietary supplements, which can cater to the health requirements of children. Nature’s Way Healthy Eyes is a supplement for better functioning and health of the eyes.

The Nature’s Bounty Co., Pfizer Inc., Vitabiotics Ltd., Bausch & Lomb, Amway International, EyeScience, Nutrivein, ZeaVision LLC, Nutrachamps, and Kemin Industries, Inc. are key suppliers of eye health supplements.

Segmentation of Eye Health Supplements Industry Research

  • By Ingredient :

    • Lutein and Zeaxanthin
    • Omega-3 Fatty Acids
    • Antioxidants
    • Coenzyme Q10
    • Flavonoids
    • Alpha-lipoic Acid
    • Astaxanthin
    • Others
  • By Indication :

    • Age-related Macular Degeneration (AMD)
    • Cataract
    • Dry Eye syndrome
    • Inflammation
    • Others
  • By Formulation :

    • Tablets
    • Capsules
    • Powder
    • Softgels
    • Liquid
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Table of Content

1. Global Market - Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Eye Health Supplements

        3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices

        3.1.3. COVID-19 Impact Benchmark with Previous Crisis

            3.1.3.1. Change in Demand

            3.1.3.2. Before and After COVID-19 Crisis (Projected)

            3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)

            3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)

        3.1.4. Impact on Market and Value (US$ Mn)

            3.1.4.1. Likely Loss of Value in 2022

            3.1.4.2. Mid-term and Long Term Forecast

            3.1.4.3. Quarter by Quarter Demand and Recovery Assessment

        3.1.5. Anticipated Demand and Value Recovery Curve

            3.1.5.1. Likelihood of U-Shape Recovery

            3.1.5.2. Likelihood of L-Shape Recovery

        3.1.6. Recovery Period Assessment by Key Countries

        3.1.7. Recovery Assessment by Key Market Segments

        3.1.8. Action Points and Recommendations for Suppliers

        3.1.9. Impact on Trade Balance

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Source Development Trends

4. Market Background and foundation Data Points

    4.1. Need of the Hour for Industries

    4.2. Industry Wise Industry 4.0

    4.3. Strategic Priorities

    4.4. Life Cycle Stage

    4.5. Importance of Technology

    4.6. Use Cases of Eye Health Supplements

    4.7. Forecast Factors: Relevance and Impact

    4.8. Investment Feasibility Matrix

    4.9. PESTLE Analysis

    4.10. Porter’s Five Forces Analysis

    4.11. Market Dynamics

        4.11.1. Drivers

        4.11.2. Restraints

        4.11.3. Opportunity Analysis

        4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Ingredient

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Ingredient, 2018 to 2022

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Ingredient, 2023 to 2033

        6.3.1. Lutein and Zeaxanthin

        6.3.2. Omega-3 Fatty Acids

        6.3.3. Antioxidants

        6.3.4. Coenzyme Q10

        6.3.5. Flavonoids

        6.3.6. Alpha-lipoic Acid

        6.3.7. Astaxanthin

        6.3.8. Others

    6.4. Market Attractiveness Analysis By Ingredient

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Indication , 2018 to 2022

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Indication, 2023 to 2033

        7.3.1. Age-related Macular Degeneration (AMD)

        7.3.2. Cataract

        7.3.3. Dry Eye syndrome

        7.3.4. Inflammation

        7.3.5. Others

    7.4. Market Attractiveness Analysis By Indication

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Formulation

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By Formulation, 2018 to 2022

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Formulation, 2023 to 2033

        8.3.1. Tablets

        8.3.2. Capsules

        8.3.3. Powder

        8.3.4. Softgels

        8.3.5. Liquid

    8.4. Market Attractiveness Analysis By Formulation

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        10.3.1. By Country

            10.3.1.1. United States

            10.3.1.2. Canada

        10.3.2. By Ingredient

        10.3.3. By Indication

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Ingredient

        10.4.3. By Indication

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Ingredient

        11.3.3. By Indication

        11.3.4. By Formulation

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Ingredient

        11.4.3. By Indication

        11.4.4. By Formulation

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. France

            12.3.1.3. Italy

            12.3.1.4. Spain

            12.3.1.5. United Kingdom

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Ingredient

        12.3.3. By Indication

        12.3.4. By Formulation

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Ingredient

        12.4.3. By Indication

        12.4.4. By Formulation

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Ingredient

        13.3.3. By Indication

        13.3.4. By Formulation

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Ingredient

        13.4.3. By Indication

        13.4.4. By Formulation

14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Malaysia

            14.3.1.4. Singapore

            14.3.1.5. Vietnam

            14.3.1.6. ANZ

            14.3.1.7. Rest of South Asia & Oceania

        14.3.2. By Ingredient

        14.3.3. By Indication

        14.3.4. By Formulation

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Ingredient

        14.4.3. By Indication

        14.4.4. By Formulation

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Israel

            15.3.1.4. Rest of Middle East and Africa (MEA)

        15.3.2. By Ingredient

        15.3.3. By Indication

        15.3.4. By Formulation

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Ingredient

        15.4.3. By Indication

        15.4.4. By Formulation

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. The Nature’s Bounty Co.

            17.3.1.1. Company Overview

            17.3.1.2. Source overview

            17.3.1.3. SWOT Analysis

            17.3.1.4. Key Developments

        17.3.2. Pfizer Inc.

            17.3.2.1. Company Overview

            17.3.2.2. Source overview

            17.3.2.3. SWOT Analysis

            17.3.2.4. Key Developments

        17.3.3. Vitabiotics Ltd.

            17.3.3.1. Company Overview

            17.3.3.2. Source overview

            17.3.3.3. SWOT Analysis

            17.3.3.4. Key Developments

        17.3.4. Bausch & Lomb

            17.3.4.1. Company Overview

            17.3.4.2. Source overview

            17.3.4.3. SWOT Analysis

            17.3.4.4. Key Developments

        17.3.5. Kemin Industries, Inc.

            17.3.5.1. Company Overview

            17.3.5.2. Source overview

            17.3.5.3. SWOT Analysis

            17.3.5.4. Key Developments

        17.3.6. Amway International

            17.3.6.1. Company Overview

            17.3.6.2. Source overview

            17.3.6.3. SWOT Analysis

            17.3.6.4. Key Developments

        17.3.7. EyeScience

            17.3.7.1. Company Overview

            17.3.7.2. Source overview

            17.3.7.3. SWOT Analysis

            17.3.7.4. Key Developments

        17.3.8. Wellbeing Nutrition

            17.3.8.1. Company Overview

            17.3.8.2. Source overview

            17.3.8.3. SWOT Analysis

            17.3.8.4. Key Developments

        17.3.9. Nutrivein

            17.3.9.1. Company Overview

            17.3.9.2. Source overview

            17.3.9.3. SWOT Analysis

            17.3.9.4. Key Developments

        17.3.10. ZeaVision LLC

            17.3.10.1. Company Overview

            17.3.10.2. Source overview

            17.3.10.3. SWOT Analysis

            17.3.10.4. Key Developments

        17.3.11. Nutrachamps

            17.3.11.1. Company Overview

            17.3.11.2. Source overview

            17.3.11.3. SWOT Analysis

            17.3.11.4. Key Developments

        17.3.12. Kemin Industries, Inc.

            17.3.12.1. Company Overview

            17.3.12.2. Source overview

            17.3.12.3. SWOT Analysis

            17.3.12.4. Key Developments

18. Assumptions And Acronyms Used

19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 02: Global Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 04: Global Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 05: Global Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 07: Global Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 08: Global Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 16: North America Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 17: North America Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 19: North America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 20: North America Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 22: North America Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 23: North America Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 28: Latin America Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 29: Latin America Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 31: Latin America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 32: Latin America Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 34: Latin America Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 35: Latin America Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 40: Europe Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 41: Europe Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 43: Europe Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 44: Europe Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 46: Europe Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 47: Europe Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 52: East Asia Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 53: East Asia Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 55: East Asia Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 56: East Asia Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 58: East Asia Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 59: East Asia Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033

Table 76: MEA Market Value (US$ Mn) Analysis, by Ingredient, 2018 to 2022

Table 77: MEA Market Value (US$ Mn) Analysis, by Ingredient, 2023 to 2033

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Ingredient, 2023 to 2033

Table 79: MEA Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022

Table 80: MEA Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033

Table 82: MEA Market Value (US$ Mn) Analysis, by Formulation, 2018 to 2022

Table 83: MEA Market Value (US$ Mn) Analysis, by Formulation, 2023 to 2033

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Formulation, 2023 to 2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033

Figure 05: Global Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 06: Global Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 07: Global Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 08: Global Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 09: Global Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 10: Global Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 11: Global Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 12: Global Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 13: Global Market Attractiveness Analysis by Formulation, 2023 to 2033

Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033

Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033

Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033

Figure 21: North America Market Share Analysis by Country, 2023 & 2033

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 24: North America Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 25: North America Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 26: North America Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 27: North America Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 28: North America Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 29: North America Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 30: North America Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 31: North America Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 32: North America Market Attractiveness Analysis by Formulation, 2023 to 2033

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033

Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 40: Latin America Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 41: Latin America Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 42: Latin America Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 43: Latin America Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 44: Latin America Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 45: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 46: Latin America Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 47: Latin America Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 48: Latin America Market Attractiveness Analysis by Formulation, 2023 to 2033

Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033

Figure 53: Europe Market Share Analysis by Country, 2023 & 2033

Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033

Figure 56: Europe Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 57: Europe Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 58: Europe Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 59: Europe Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 60: Europe Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 61: Europe Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 62: Europe Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 63: Europe Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 64: Europe Market Attractiveness Analysis by Formulation, 2023 to 2033

Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033

Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033

Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 72: East Asia Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 73: East Asia Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 74: East Asia Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 75: East Asia Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 76: East Asia Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 77: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 78: East Asia Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 79: East Asia Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 80: East Asia Market Attractiveness Analysis by Formulation, 2023 to 2033

Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033

Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033

Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033

Figure 88: South Asia & Oceania Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 90: South Asia & Oceania Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 91: South Asia & Oceania Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 93: South Asia & Oceania Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 94: South Asia & Oceania Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 96: South Asia & Oceania Market Attractiveness Analysis by Formulation, 2023 to 2033

Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022

Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033

Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033

Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033

Figure 101: MEA Market Share Analysis by Country, 2023 & 2033

Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033

Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033

Figure 104: MEA Market Share and BPS Analysis by Ingredient, 2023 & 2033

Figure 105: MEA Market Y-o-Y Growth Projections by Ingredient, 2023 to 2033

Figure 106: MEA Market Attractiveness Analysis by Ingredient, 2023 to 2033

Figure 107: MEA Market Share and BPS Analysis by Indication, 2023 & 2033

Figure 108: MEA Market Y-o-Y Growth Projections by Indication, 2023 to 2033

Figure 109: MEA Market Attractiveness Analysis by Indication, 2023 to 2033

Figure 110: MEA Market Share and BPS Analysis by Formulation, 2023 & 2033

Figure 111: MEA Market Y-o-Y Growth Projections by Formulation, 2023 to 2033

Figure 112: MEA Market Attractiveness Analysis by Formulation, 2023 to 2033

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the eye health supplements market value in 2023?

The global eye health supplements market stands at US$ 1.9 billion in 2023.

What was the share of the lutein and zeaxanthin segment in the eye health supplements market in 2022?

The lutein and zeaxanthin segment held 32% share of the global eye health supplements market in 2022.

What was the revenue share of tablet-based eye health supplements in 2022?

Tablet-based eye health supplements accounted for 41% share of the global market revenue in 2022.

At what CAGR is the demand for eye health supplements forecasted to increase?

Sales of eye health supplements are forecasted to rise at a CAGR of 6.2% from 2023 to 2033.

What is the projected valuation of the eye health supplements market for 2033?

Demand for eye health supplements is set to reach a market value of US$ 3.5 billion by the end of 2033.

Eye Health Supplements Market

Schedule a Call